Akèy › Anplwayè › Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.: Salè H-1B ak pajon
Lyell Immunopharma, Inc. depoze 8 aplikasyon kondisyon travay pou visa H-1B ak visa ki gen rapò nan ane fiskal 2023–2026; sètifye: 8. Medyèn salè yo ofri a: $181,171.
Èske Lyell Immunopharma, Inc. pajone visa H-1B?
Lyell Immunopharma, Inc. depoze 8 aplikasyon kondisyon travay nan ane fiskal 2023–2026, dènye a soumèt sou Feb 6, 2026. Yon LCA se premye etap yon demann H-1B, konsa anplwayè a pajone oswa prepare pou pajone travayè H-1B; li pa garanti pajon pou okenn travay espesifik. Tcheke lis travay pwòp anplwayè a.
Salè pa tit travay
| Tit travay | LCA | Salè medyan |
|---|---|---|
| Sr. Director, Total Rewards | 2 | $236,639 |
| Sr. Business Analyst, Financial Systems | 2 | $160,682 |
| Clinical Data Platform Product Manager | 1 | $200,000 |
| Senior Scientist, Translational Pathology Laboratory | 1 | $144,000 |
| Scientist II | 1 | $160,169 |
| Senior Director, Medical Affairs, Solid Tumors | 1 | $291,304 |
Aplikasyon pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2023 | 3 | $195,500 |
| FY2024 | 2 | $177,262 |
| FY2025 | 2 | $152,084 |
| FY2026 | 1 | $291,304 |
Nivo salè prevanlan
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Kote travay yo ye
Okipasyon
- Compensation and Benefits Managers2
- Computer Systems Analysts2
- Computer and Information Systems Managers1
- Medical Scientists, Except Epidemiologists1
- Molecular and Cellular Biologists1
- Natural Sciences Managers1
Dènye aplikasyon yo
| Tit travay | Salè baz | Kote | Soumèt | Dat kòmansman | Estati |
|---|---|---|---|---|---|
| Senior Director, Medical Affairs, Solid Tumors | $291,304–$330,000 Nivo IV | Redwood City, CA | Feb 6, 2026 | Mar 23, 2026 | Certifye |
| Scientist II | $160,169–$173,000 | South San Francisco, CA | Jun 12, 2025 | Jun 12, 2025 | Certifye |
| Senior Scientist, Translational Pathology Laboratory | $144,000–$216,000 Nivo III | South San Francisco, CA | Nov 12, 2024 | Feb 15, 2025 | Certifye, apre retire |
| Sr. Business Analyst, Financial Systems | $154,523–$180,000 Nivo IV | South San Francisco, CA | Apr 10, 2023 | Jul 6, 2023 | Certifye, apre retire |
| Sr. Director, Total Rewards | $195,500–$280,000 Nivo IV | South San Francisco, CA | Jan 10, 2023 | Jan 20, 2023 | Certifye |
| Sr. Business Analyst, Financial Systems | $166,842 Nivo IV | South San Francisco, CA | Jan 5, 2023 | Jul 6, 2023 | Certifye |
| Sr. Director, Total Rewards | $277,778 E-3 · Nivo IV | South San Francisco, CA | Nov 21, 2022 | Dec 16, 2022 | Certifye |
| Clinical Data Platform Product Manager | $200,000 Nivo III | Seattle, WA | Aug 30, 2021 | Sep 6, 2021 | Certifye, apre retire |
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).